Recent Finacing
Recent Raise
Third Harmonic Bio is a clinical-stage biotech developing THB001, a selective oral KIT inhibitor to deplete mast cells and reduce mast cell–driven inflammation, with Phase 1b for cold-induced urticaria.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Third Harmonic Bio.
